Cytek Biosciences, Inc. Common Stock
CTKBCytek Biosciences, Inc. is a biotechnology company specializing in developing and manufacturing advanced spectral flow cytometry instruments. Founded to improve cellular analysis, it offers innovative solutions for research and clinical laboratories, enabling detailed immune profiling and cellular characterization through high-parameter, multicolor flow cytometry systems.
Company News
Cytek Biosciences unveiled its new 7-laser Cytek Borealis full spectrum flow cytometer featuring Deep Ultraviolet and Infrared capabilities with 120 detectors, enabling high-resolution 60-color panels. The company also announced automation-ready configurations for the Cytek Aurora Evo system designed to integrate with robotic plate handling and t...
Cytek Biosciences marks the one-year anniversary of its 8,500-square-foot Singapore facility, which has enhanced manufacturing capacity, regional service capabilities, and supply chain resilience. The facility serves as a strategic hub for Asia-Pacific operations and supports the company's growth in cell analysis solutions driven by increasing gl...
Cytek Biosciences announced preliminary Q4 2025 revenue of approximately $62 million, representing 8% year-over-year growth and 19% sequential growth. Full year 2025 revenue is expected to be approximately $201 million. The company highlighted strong growth in Services, Reagents, and Asia Pacific instrument revenue, along with improved instrument...
Cytek Biosciences was recognized by TIME and Statista as one of America's top-performing publicly listed companies, highlighting its exceptional growth, financial stability, and innovative cell analysis solutions.
Cytek Biosciences' Muse Micro cell analyzer won the 2025 BioTech Breakthrough Award for Drug Discovery Solution of the Year, highlighting its innovative approach to making cell analysis more accessible and cost-effective for laboratories.
